Delivery Order SPE2DE24D0021-SPE2D626F22EA

Fisher Scientific Company L.L.C. received a delivery order award on January 23, 2026, from the Department of Defense's Medical Supply Chain for Anti-B Bioclone 10ML products (15 packs) with a ceiling value of $1,522.11 and an ultimate completion date of February 13, 2026. The award was made under a fixed-price contract with economic price adjustment provisions and required no set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business. As a child contract award, this delivery order is issued under a larger indefinite delivery vehicle, likely a General Services Administration Multiple Award Schedule or similar pre-competed procurement mechanism that enables the Department of Defense to procure laboratory and medical supplies from pre-qualified vendors.

Fisher Scientific, a major federal vendor specializing in laboratory equipment and medical supplies since its SAM.gov registration in 2001, has an established track record supplying the Department of Defense's Medical Supply Chain with diagnostic test kits and laboratory supplies. The Anti-B Bioclone products procured under this delivery order support diagnostic operations within the federal healthcare system. Fisher Scientific's extensive federal contract portfolio, which includes significant agreements with the Department of Veterans Affairs and various health-related federal agencies, demonstrates the company's capabilities and credibility as a reliable supplier of specialized medical and laboratory products to government entities.